Community health experts call for balanced approach to continued development of promising new TB drug in a new article. They argue that research into bedaquiline -- a new drug, fast tracked for multidrug-resistant tuberculosis (MDR-TB) -- should proceed cautiously in people with drug-sensitive tuberculosis.

Source: Novel treatment for drug-resistant ..., but concerns for patient safety remain